Andrea Tan

Stock Analyst at Goldman Sachs

(0.33)
# 2594
Out of 5,354 analysts
52
Total ratings
35.71%
Success rate
-9.97%
Average return
16 Stocks
Name Action PT Current % Upside Ratings Updated
IOVA Iovance Biotherapeut...
Maintains: Buy
16 8
1.84 334.78% 7 May 12, 2025
TARS Tarsus Pharmaceutica...
Maintains: Neutral
46 51
42.69 19.47% 4 May 5, 2025
DAWN Day One Biopharmaceu...
Maintains: Buy
39 27
6.95 288.49% 6 Mar 25, 2025
INSM Insmed
Maintains: Strong Buy
74 102
73.77 38.27% 9 Jul 10, 2024
SGMT Sagimet Biosciences
Maintains: Neutral
23 6
4.05 48.15% 5 Jul 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
31
16.73 85.3% 1 Jun 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
3 2
0.74 170.27% 3 Jun 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Sell
2
3.98 -49.75% 1 Dec 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
17
n/a n/a 1 Nov 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
160
132.07 21.15% 1 Nov 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
27 24
2.42 891.74% 2 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
10 4
1.43 179.72% 2 Jan 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
178 375
279.2 34.31% 1 Dec 20, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
13
5.29 145.75% 1 Dec 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
2 2
n/a n/a 6 Nov 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
6 4
0.23 1639.13% 2 May 24, 2022